Hepion Pharmaceuticals publishes revised quarterly financial report
HEPA•Hepion Pharmaceuticals filed an amended quarterly report on November 17, correcting typographical errors in related-party disclosures for the quarter ended September 30. Financial results and all other disclosures were unchanged from its November 16 filing.
1. Amended quarterly report
Hepion Pharmaceuticals filed an amended quarterly report on November 17, 2026, correcting typographical errors in related-party disclosures for the quarter ended September 30. The amendment leaves financial results and all other disclosures unchanged from the original report filed November 16, 2026.




